ICYMI – NYT: Unable to Meet the Deductible or the Doctor

10.20.14 | By

In case you missed it, a front-page story in The New York Times this weekend told the story of Patricia Wanderlich and several other patients who, despite purchasing coverage through the health insurance exchange, or marketplace, have found high, and often combined, deductibles are a major hurdle to accessing needed care.

The ABCs of Health Coverage

10.14.14 | By

Insurance jargon can be confusing. Whether you’ve been choosing a health plan annually for years or have coverage for the first time, it can be tricky to figure out exactly what your plan covers and how to prepare for out-of-pocket costs.  

When It Comes to Getting Your Meds, Are You Covered?

10.01.14 | By

Four in five American adults take at least one medication, and more than one in four take five medicines or more. For patients to live longer, healthier lives, being able to access needed treatments is critical. Not to mention, adhering to treatment regimens can help prevent costly and burdensome complications down the road.

Health Coverage 101: Back-to-Basics

09.22.14 | By

Have you ever been confused by insurance jargon? What’s a deductible? A copay? When and how do they apply? You’re not alone. According to a national survey by the Department of Education about health literacy, just more than 1 in 10 American adults understand how to navigate medical care and health insurance.

Coverage without Access: An Analysis of Exchange Plan Benefits for Certain Medicines

A central goal of the Affordable Care Act (ACA) was to expand access to insurance so patients, particularly those with chronic disease, could access the treatments and medicines they need. Recognizing that coverage would have limited value without basic access and affordability, the ACA included a non-discrimination provision, an out-of-pocket spending cap, mandatory coverage of “essential health benefits,” and financial assistance for low-income enrollees.

Affordable Care Act

The biopharmaceutical industry’s top priority is to provide patients with access to high quality medicines. The Patient Protection and Affordable Care Act offers many Americans the opportunity to purchase health coverage through the health insurance exchange. Unfortunately, health insurance exchange coverage may not be all that patients expected. High deductibles, cost-sharing, and restrictive formularies potentially put patient health at risk.

Measuring Generic Efficiency in Part D

WUSA Anita Brikman bio

WUSA Anchor Anita Brikman

Ms. Anita Brikman spearheads WUSA9’s health coverage, including daily “Health Alerts” and in-depth reports on breaking medical news, as well as research and clinical advances.

Testimony of Richard I. Smith Before The U.S. Senate Special Committee On Aging

MAY 22, 2013

Chairman Nelson, Ranking Member Collins, and Members of the Committee, thank you for inviting me to testify on the Medicare prescription drug program, also known as Part D.


Drug Discovery and Better Health

PhRMA’s Rick Smith Testifies Before the Senate Aging Committee

WASHINGTON, D.C. (May 22, 2013) – Richard Smith, Executive Vice President of Policy and Research at Pharmaceutical Research and Manufacturers of America (PhRMA), testified today in a hearing called “10 Years Later: A Look at the Medicare Prescription Drug Program,” hosted by the U.S. Senate’s Special Committee on Aging.


Subscribe to RSS - Access